Literature DB >> 35586538

Disentangling the Phenotypes of Anti-IgLON5 Disease: When Clinical Suspicion Matters.

Daniel Macías-García1,2,3, Bettina Balint4.   

Abstract

Entities:  

Keywords:  IgLON5; autoimmune movement disorder; phenotypes

Year:  2022        PMID： 35586538      PMCID： PMC9092746          DOI： 10.1002/mdc3.13446

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  8 in total

Review 1.  Response to immunotherapy in anti-IgLON5 disease: A systematic review.

Authors:  Pablo Cabezudo-García; Natalia Mena-Vázquez; Guillermo Estivill Torrús; Pedro Serrano-Castro
Journal:  Acta Neurol Scand       Date:  2020-01-12       Impact factor: 3.209

2.  Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.

Authors:  Jon Landa; Carles Gaig; Jesús Plagumà; Albert Saiz; Ana Antonell; Raquel Sanchez-Valle; Josep Dalmau; Francesc Graus; Lidia Sabater
Journal:  Ann Neurol       Date:  2020-08-27       Impact factor: 10.422

Review 3.  Antibody-Mediated Encephalitis.

Authors:  Josep Dalmau; Francesc Graus
Journal:  N Engl J Med       Date:  2018-03-01       Impact factor: 91.245

4.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

5.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Authors:  Lidia Sabater; Carles Gaig; Ellen Gelpi; Luis Bataller; Jan Lewerenz; Estefanía Torres-Vega; Angeles Contreras; Bruno Giometto; Yaroslau Compta; Cristina Embid; Isabel Vilaseca; Alex Iranzo; Joan Santamaría; Josep Dalmau; Francesc Graus
Journal:  Lancet Neurol       Date:  2014-04-03       Impact factor: 44.182

6.  Neuropathological criteria of anti-IgLON5-related tauopathy.

Authors:  Ellen Gelpi; Romana Höftberger; Francesc Graus; Helen Ling; Janice L Holton; Timothy Dawson; Mara Popovic; Janja Pretnar-Oblak; Birgit Högl; Erich Schmutzhard; Werner Poewe; Gerda Ricken; Joan Santamaria; Josep Dalmau; Herbert Budka; Tamas Revesz; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

7.  Ocular Motor Abnormalities in Anti-IgLON5 Disease.

Authors:  Stefan Macher; Ivan Milenkovic; Tobias Zrzavy; Romana Höftberger; Stefan Seidel; Evelyn Berger-Sieczkowski; Thomas Berger; Paulus S Rommer; Gerald Wiest
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

Review 8.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.